Machine learning is an essential component of artificial intelligence. Whether it’s powering recommendation engines, fraud detection systems, self-driving cars, generative AI, or any of the countless ...

https://www.thehindubusinessline.com/news/real-estate/google-parent-gains-exclusive-option-on-more-space-at-bengalurus-alembic-city/article70592100.ece Copy Google ...

Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) difluprednate ...

Fintel reports that on January 15, 2026, Alembic Global initiated coverage of ATI (NYSE:ATI) with a Overweight recommendation. Analyst Price Forecast Suggests 1.04% Downside As of January 14, 2026, ...

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received tentative approval from the US Food & Drug ...

Alembic Pharmaceuticals was hit with a patent infringement lawsuit on Dec. 19 in New York Eastern District Court over its planned generic version of the glaucoma treatment LUMIGAN®. The action, ...

New Delhi: Accenture has invested in Alembic, an AI-powered causal marketing intelligence platform, and entered into a strategic partnership to help brands link their marketing activity more directly ...

Alembic Pharmaceuticals share price rose 2 percent in the opening trade on November 17 following the company received final approval from USFDA for angina drug. At 09:19am, Alembic Pharmaceuticals was ...

Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...